Global /India /Healthcare /Drug Manufacturers - General /BROOKS
chevron_leftBack
Brooks Laboratories Ltd. logo

Brooks Laboratories Ltd.

BROOKS
NSE: BROOKS Delayed
55.98INR -4.9%
0.5929 USD
As of 20 June 2026, Brooks Laboratories Ltd. has a market cap of $18.37M USD, ranking #37688 globally and #2728 in India. It ranks #3377 in the Healthcare sector, and #1121 in the Drug Manufacturers - General industry.
Global Rank
37688
Country Rank
2728
Sector Rank
3377
Industry Rank
1121
Key Stats
Market Cap
$18.37MUSD
1.73B INR
Enterprise Value
$19.08MUSD
1.8B INR
Revenue (TTM)
$9.41MUSD
888.46M INR
EBITDA (TTM)
$826.3KUSD
78.02M INR
Net Income (TTM)
$2.29MUSD
216.03M INR
EBITDA Margin
8.8%
Profit Margin
24%
PE Ratio
8.0
PS Ratio
2.0
PB Ratio
1.5
EV/EBITDA
7.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
323
Founded
2002
Website
brookslabs.net open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-4.9% -8.1% 36% -8.6% -45% -57%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
BROOKS
Brooks Laboratories Ltd
ISIN: INE650L01011
Shares Out.:
29.457M1
TV:
SA:
YF:
GF:
BA:
MS:
55.98 INR
Bombay Stock Exchange
MIC: XBOM
533543 (BROOKS)
Brooks Laboratories Ltd
ISIN: INE650L01011
TV:
SA:
YF:
GF:
BA:
MS:
59.45 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Brooks Laboratories Ltd.

Brooks Laboratories Limited provides contract development and manufacturing services for pharmaceutical companies in India and internationally. The company’s product portfolio includes liquid injection ampoules and vials, dry powder injection vials, lyophilized injections, eye/ear drops, and nasal drops; B-Lactam and cephalosporin tablets, dry powder syrups, and injections; general, liquid, and dry powder injections; formulations for antibiotics, pain management, and controlled drugs; and oncology products and hormonal injections, etc. It also provides regulatory compliance, custom branding and packaging, scalable production, and end-to-end support services. The company serves government health programs and public sector institutions, hospitals and medical colleges, defense and railways, corporate healthcare, and NGOs. It exports its products to Afghanistan, Yemen, Kosovo, Bolivia, Guatemala, Turkmenistan Nigeria, Lebanon, Mauritius, Sudan, Madagascar, DR Congo, Mozambique, LATAM, and Africa. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$45.22B
4.27T INR
246K%
39.1
DIVISLAB
$18.38B
1.73T INR
100K%
70.0
$15.17B
1.43T INR
82K%
63.0
$11.73B
1.11T INR
64K%
19.6
MANKIND
$9.87B
931.67B INR
54K%
52.2
ZYDUSLIFE
$9.71B
916.53B INR
53K%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
4M%
38.1
JNJ
$547.28B
3M%
26.4
ABBV
$360.63B
2M%
97.4
$318.3B
256.25B CHF
2M%
19.9
AZN
$284.64B
215.59B GBP
2M%
27.6
MRK
$274.03B
1M%
15.1
chevron_leftBack